27
Views
3
CrossRef citations to date
0
Altmetric
Experimental and Clinical Research

Antifungal Activity of Amphotericin B and Itraconazole against Filamentous Fungi: Comparison of the Sensititre Yeast OneŴ and NCCLS M38-A Reference Methods

Pages 468-473 | Published online: 18 Jul 2013

REFERENCES

  • LaRocco MT, Burgert SJ. Fungal infections in the tran-splant recipient and laboratory methods for diagnosis. Rev Iberoam Micol 1997; 14: 143–146.
  • Beck-Sague C, Jarvis WR, the National Nosocomial Infection Surveillance System. Secular trends in the epidemio-logy of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993; 167: 1247–1251.
  • Rachel R. Mycotic infections in the immunocompromi-sed patient. Rev Iberoam Micol 1996; 13(Supl. 1): S20-S24.
  • Trick WE, Jarvis WR. Epidemiology of nosocomial fungal infections in the 1990s. Rev Iberoam Micol 1998; 15: 2–6.
  • Rex JH, Pfaller MA, Rinaldi MG, Polak A, Galgiani JN. Antifungal susceptibility testing. Clin Microbiol Rev 1993; 6: 367–381.
  • Rubio-Calvo MC, Gil-Tomás J, Benito-Ruesca R. Las pruebas in vitro en la evaluaci6n de los agentes antiftingicos. Rev Esp Quimoter 1993; 6: 21.
  • Pemán-Garcia J, Cant6n-Lacasa E. Las pruebas de sen-sibilidad antiftingica en un laboratorio de microbiologia clinica. Rev Esp Quimioter 1996; 9: 17–20.
  • Odds FC. Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response? Drug Resistance Updates 1998; 1: 11–15.
  • Espinel-Ingroff A. Clinical utility of in vitro antifungal susceptibility testing. Rev Iberoam Micol 2000; 13: 161–166.
  • Odds FC. Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes? Rev Iberoam Micol 1997; 14: 83–84.
  • Espinel-Ingroff A, Warnock DW, Vazquez JA, Arthimgton-Skaggs BA. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance. Med Mycol 2000; 38: 293–304.
  • National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-2A. National Committee for Clinical Laboratory Standards, Villanova, Pa, 2002.
  • Espinel-Ingroff A, Bartlett M, Bowden R, Chin NX, Cooper C, Fothergill A, et al. Multicenter evaluation of propo-sed standardization procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol 1997; 35: 139–43.
  • National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed stan-dard M38-A.1998.
  • Espinel-Ingroff A. Comparison of in vitro activities of the new triazole 5CH56592 and echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950–2956.
  • Espinel-ingroff A. Germinated and nongerminated coni-dial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravucona-zole and voriconazole. Antimicrob Agents Chemother 2001; 45: 605–607.
  • Manavathu EK, Cutright JL, Loebenberh D, Chandrasekar PH. A comparative study of the in vitro suscep-tibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (5CH56592). J Antimicrob Chemother 2000; 46: 229–234.
  • Odds FC, Van Gerven F, Espinel-Ingroff A, Bartlett MS, Ghannoum MA, Lancaster MV, et al. Evaluation of possi-ble correlations between antifungal susceptibilities of filamen-tous fungi in vitro and antifungal treatment outcomes in ani-mal infection models. Antimicrob Agents Chemother 1998; 42: 282–288.
  • Guarro J, Pujol I, Mayayo E. In vitro and in vivo experi-mental activities of antifungal agents against Fusarium solani. Antimicrob Agents Chemother 1999; 43: 1256–1257.
  • Carrillo-Munoz AJ, Quind6s G, Ruesga M, del Valle O, Pemán J, CantOn E, et al. In vitro antifungal susceptibility testing of filamentous fungi with Sensititrem Yeast One. Mycoses 2004; 47 (accepted for publication).
  • Espinel-Ingroff A. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol 2001; 39: 1360-1367.
  • Meletiadis J, Mouton JW, Meis JF, Bouman BA, Verweij PE. Comparison of the E-test and the sensititre colori-metric methods with the NCCLS proposed standard for anti-fungal susceptibility testing of Aspergillus species. J.Clin Microbiol 2002; 40: 2876–2885.
  • Martin-Mazuelos E, Peman J, Valverde A, Chaves M, Serrano MC, Canton E. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphote-ricin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrob Chemother 2003; 52: 365–370.
  • Carrillo-Muñoz AJ, Pemán J, Gobernado M. Nuevos antiftingicos. Rev Esp Quimioter 1999; 12: 181–204.
  • Carrillo-Muñoz AJ, BriO S, Quind6s G. Una nueva generaci6n de fármacos antifangicos. Rev Iberoam Micol 2001; 18: 4–7.
  • Pfaller MA, Vu Q, Lancaster M, Espinel-Ingroff A, Fothergill A, Grant C, et al. Multisite reproducibility of colori-metric broth microdilution method for antifungal susceptibility testing of yeasts isolates. J Clin Microbiol 1994; 32: 1625–1628.
  • To WK, Fothergill AW, Rinaldi MG. Comparative eva-luation of macrodilution and Alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast iso-lates. J Clin Microbiol 1995; 33: 2660–2664.
  • Jahn B, Stüben A, Bhakdi S. Colorimetric testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromi-de and alamar blue tests. J Clin Microbiol 1996; 34: 2039-2041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.